How is Tildrakizumab-asmn dosed?
The recommended dosage of Tildrakizumab-asmn is an initial dose at weeks 0 and 4, followed by a maintenance dose every 12 weeks thereafter.
What is the dosage form of Tildrakizumab-asmn?
Tildrakizumab-asmn is available in the form of a solution for subcutaneous administration.
How is Tildrakizumab-asmn administered?
Tildrakizumab-asmn is administered as a subcutaneous injection by a healthcare professional in a medical facility. The injection is typically given in the stomach, thighs, or upper arms.
What are common precautions when taking Tildrakizumab-asmn?
Before using Tildrakizumab-asmn, inform your doctor about any allergies you have, including allergies to foods, dyes, preservatives, or animals. It should not be used in patients with active infections, including tuberculosis. If you have a chronic infection or a history of recurring infections, consult your doctor before starting treatment. If you have inactive tuberculosis, complete the treatment before starting Tildrakizumab-asmn therapy. Consult your doctor before using Tildrakizumab-asmn while breastfeeding, as there is limited information available on its safety. Inform your doctor about any other medications you are taking, as there might be drug interactions that could impact your treatment. Tildrakizumab-asmn should only be administered by a trained healthcare professional in a medical facility. Discuss any other medical conditions you have with your doctor, as they may impact the use of Tildrakizumab-asmn. Always follow your doctor's instructions and monitor for any side effects or reactions.